Wolf, Dennis 1980-
Wolf, D.
Dennis Wolf onderzoeker
VIAF ID: 292457183 (Personal)
Permalink: http://viaf.org/viaf/292457183
Preferred Forms
- 100 0 _ ‡a Dennis Wolf ‡c onderzoeker
-
- 100 1 _ ‡a Wolf, Dennis ‡d 1980-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
IL-2 trägt zur Zirrhose-assoziierten Immundysfunktion durch Beeinträchtigung der Funktion follikulärer T-Helferzellen bei | |
ApoB-specific CD4+ T cells in mouse and human atherosclerosis | |
Autoimmune Regulator (AIRE) deficiency does not affect atherosclerosis and CD4 T cell immune tolerance to Apolipoprotein B | |
[caption title:] Componirt v. Jos Schnabel | dem Kapellmeister | |
[caption title, score:] An Gott. (Ites Heft), pag. 1. | |
CD40L and its receptors in atherothrombosis - an update | |
Circulating autoantibodies recognizing immunodominant epitopes from human apolipoprotein B associate with cardiometabolic risk factors, but not with atherosclerotic disease | |
A comparative gene expression matrix in Apoe-deficient mice identifies unique and atherosclerotic disease stage-specific gene regulation patterns in monocytes and macrophages | |
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany | |
Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency | |
A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction | |
Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis | |
Dysregulation of the mitochondrial proteome occurs in mice lacking adiponectin receptor 1 | |
Editorial: Immune and autoimmune mechanisms in cardiovascular disease | |
Effects of renal denervation vs Sham in resistant hypertension after medication escalation : prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized clinical trial | |
Effects of short term adiponectin receptor agonism on cardiac function and energetics in diabetic db/db mice | |
Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury | |
Generierung und Charakterisierung eines neuen Liganden- und Aktivitäts-spezifischen Antikörpers zur selektiven Hemmung der CD40L/Mac-1 Interaktion | |
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice | |
An Gott | |
Heterogeneity of T cells in atherosclerosis defined by single-cell RNA-sequencing and cytometry by time of flight | |
In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany | |
Inflammatory cell recruitment in cardiovascular disease | |
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering | |
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense | |
Modulating autoimmunity against LDL: development of a vaccine against atherosclerosis | |
Molecular mechanisms underlying NLRP3 inflammasome activation and IL-1β production in air pollution fine particulate matter (PM2.5)-primed macrophages | |
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice | |
Nonpreferential but detrimental accumulation of macrophages with clonal hematopoiesis-driver mutations in cardiovascular tissues | |
Outcomes of female and male patients suffering from coronary artery disease : a nation-wide registry of patients admitted as emergency | |
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice | |
P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction | |
P2Y12 inhibition in murine myocarditis results in reduced platelet infiltration and preserved ejection fraction | |
Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells | |
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome | |
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile | |
Real-time magnetic resonance imaging - guided coronary intervention in a porcine model | |
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort | |
role of tumor necrosis factor associated factors (TRAFs) in vascular inflammation and atherosclerosis | |
O salutaris hostia | |
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial | |
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction | |
Serotonin transporter-deficient mice display enhanced adipose tissue inflammation after chronic high-fat diet feeding | |
serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors: an observational study | |
Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH | |
Treatment of pure aortic regurgitation using surgical or transcatheter aortic valve replacement between 2018 and 2020 in Germany |